Mark A. Emalfarb
Dyadic International, Inc.
Known as a pioneer of the stone-washed blue jean industry, a member of the Iowa Hawkeye NCAA Championship wrestling teams, Mark Emalfarb, CEO of Dyadic (OTCQX:DYAI) founded Dyadic in 1979. Since then, Mr. Emalfarb has successfully led and managed the evolution of Dyadic from its origins in the stone-washing business to the discovery, development, manufacturing and commercialization of specialty enzymes and other proteins, including human vaccines derived from DNA which are used in various applications to help feed, fuel and heal humankind. Mr. Emalfarb is an inventor of over 25 U.S. and foreign biotechnology patents, and is the architect behind the creation and development of Dyadic’s revolutionary patented C1 Protein Expression System,based on a recombinant Myceliopthora thermophile fungus. Mr. Emalfarb is also responsible for the formation of several strategic research, development, manufacturing and marketing relationships with U.S. and European global partners such as Sanofi Pasteur (human vaccines), BASF (food, feed and other enzymes),Abengoa (renewable non-food biofuels), and others.
discovery, development, manufacturing and commercialization of specialty enzymes and other proteins, including human vaccines derived from DNA